{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:43:04Z","timestamp":1791286984202,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370167"],"award-info":[{"award-number":["82370167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515012118"],"award-info":[{"award-number":["2023A1515012118"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-024-02162-0","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:40:29Z","timestamp":1730104829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+\u2009leukemia stem cells"],"prefix":"10.1186","volume":"23","author":[{"given":"Chengwu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingrui","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbo","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjie","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunte","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"issue":"1","key":"2162_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13045-019-0729-2","volume":"12","author":"S Soverini","year":"2019","unstructured":"Soverini S, Bassan R, Lion T. Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges. J Hematol Oncol. 2019;12(1):39.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2162_CR2","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","volume":"37","author":"TP Braun","year":"2020","unstructured":"Braun TP, Eide CA, Druker BJ. Response and resistance to BCR-ABL1-targeted therapies. Cancer Cell. 2020;37(4):530\u201342.","journal-title":"Cancer Cell"},{"issue":"6","key":"2162_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s13238-015-0143-7","volume":"6","author":"H Zhou","year":"2015","unstructured":"Zhou H, Xu R. Leukemia stem cells: the root of chronic myeloid leukemia. Protein Cell. 2015;6(6):403\u201312.","journal-title":"Protein Cell"},{"issue":"23","key":"2162_CR4","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1182\/blood-2015-11-679928","volume":"128","author":"B Zhang","year":"2016","unstructured":"Zhang B, et al. Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells. Blood. 2016;128(23):2671\u201382.","journal-title":"Blood"},{"issue":"6","key":"2162_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cmet.2022.04.004","volume":"34","author":"C Liu","year":"2022","unstructured":"Liu C, et al. Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML. Cell Metab. 2022;34(6):818-e8357.","journal-title":"Cell Metab"},{"issue":"1","key":"2162_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-022-01602-z","volume":"21","author":"C Nicot","year":"2022","unstructured":"Nicot C. PRMT7: a survive-or-die switch in cancer stem cells. Mol Cancer. 2022;21(1):127.","journal-title":"Mol Cancer"},{"issue":"2","key":"2162_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2162_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40164-023-00427-w","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng X, et al. Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy. Exp Hematol Oncol. 2023;12(1):65.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2162_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47.","journal-title":"Mol Cancer"},{"issue":"1","key":"2162_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40164-023-00411-4","volume":"12","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis. Exp Hematol Oncol. 2023;12(1):47.","journal-title":"Exp Hematol Oncol"},{"issue":"10","key":"2162_CR11","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, et al. GPX4 in cell death, autophagy, and disease. Autophagy. 2023;19(10):2621\u201338.","journal-title":"Autophagy"},{"issue":"1","key":"2162_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s41232-022-00220-y","volume":"42","author":"W Wang","year":"2022","unstructured":"Wang W, et al. Therapy-resistant nature of cancer stem cells in view of iron metabolism. Inflamm Regen. 2022;42(1):34.","journal-title":"Inflamm Regen"},{"issue":"1","key":"2162_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12935-024-03329-x","volume":"24","author":"R Yu","year":"2024","unstructured":"Yu R, et al. Iron metabolism: backfire of cancer cell stemness and therapeutic modalities. Cancer Cell Int. 2024;24(1):157.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"2162_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405\u201314.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2162_CR15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou Y, et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun. 2019;10(1):1617.","journal-title":"Nat Commun"},{"issue":"720","key":"2162_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023;15(720): eadg3049.","journal-title":"Sci Transl Med"},{"issue":"7679","key":"2162_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551(7679):247\u201350.","journal-title":"Nature"},{"key":"2162_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbrc.2021.08.082","volume":"576","author":"L Han","year":"2021","unstructured":"Han L, et al. PPARG-mediated ferroptosis in dendritic cells limits antitumor immunity. Biochem Biophys Res Commun. 2021;576:33\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7939","key":"2162_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612(7939):338\u201346.","journal-title":"Nature"},{"issue":"5","key":"2162_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33(5):1001\u201312.","journal-title":"Cell Metab"},{"issue":"7","key":"2162_CR21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020;21(7):736\u201345.","journal-title":"Nat Immunol"},{"issue":"2","key":"2162_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cmet.2020.04.019","volume":"32","author":"M Bernier","year":"2020","unstructured":"Bernier M, et al. Disulfiram treatment normalizes body weight in obese mice. Cell Metab. 2020;32(2):203-e2144.","journal-title":"Cell Metab"},{"issue":"3","key":"2162_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/BS9.0000000000000117","volume":"4","author":"D Nie","year":"2022","unstructured":"Nie D, et al. Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis. Blood Sci. 2022;4(3):152\u20134.","journal-title":"Blood Sci"},{"issue":"4","key":"2162_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/JLB.5MA1121-644R","volume":"112","author":"C Chen","year":"2022","unstructured":"Chen C, et al. Anticancer effects of disulfiram in T-cell malignancies through NPL4-mediated ubiquitin\u2013proteasome pathway. J Leukoc Biol. 2022;112(4):919\u201329.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2162_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40364-021-00270-3","volume":"9","author":"K Li","year":"2021","unstructured":"Li K, et al. Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia. Biomark Res. 2021;9(1):17.","journal-title":"Biomark Res"},{"issue":"7684","key":"2162_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott Z, et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017;552(7684):194\u20139.","journal-title":"Nature"},{"issue":"4","key":"2162_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-2141.2008.07221.x","volume":"142","author":"ES Jose-Eneriz","year":"2008","unstructured":"Jose-Eneriz ES, et al. BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia. Br J Haematol. 2008;142(4):571\u201382.","journal-title":"Br J Haematol"},{"issue":"12","key":"2162_CR28","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1021\/acschembio.2c00445","volume":"17","author":"JP Liu","year":"2022","unstructured":"Liu JP, et al. A class of disulfide compounds suppresses ferroptosis by stabilizing GPX4. ACS Chem Biol. 2022;17(12):3389\u2013406.","journal-title":"ACS Chem Biol"},{"issue":"12","key":"2162_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41419-023-06300-2","volume":"14","author":"X Sun","year":"2023","unstructured":"Sun X, et al. Imatinib induces ferroptosis in gastrointestinal stromal tumors by promoting STUB1-mediated GPX4 ubiquitination. Cell Death Dis. 2023;14(12):839.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2162_CR30","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1038\/s41467-023-41167-z","volume":"14","author":"B Zhang","year":"2023","unstructured":"Zhang B, et al. Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis. Nat Commun. 2023;14(1):5325.","journal-title":"Nat Commun"},{"key":"2162_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102317","volume":"52","author":"S Ouyang","year":"2022","unstructured":"Ouyang S, et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022;52: 102317.","journal-title":"Redox Biol"},{"issue":"1","key":"2162_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12943-024-01999-9","volume":"23","author":"J Diao","year":"2024","unstructured":"Diao J, et al. Ferroptotic therapy in cancer: benefits, side effects, and risks. Mol Cancer. 2024;23(1):89.","journal-title":"Mol Cancer"},{"issue":"8","key":"2162_CR33","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1073\/pnas.1819728116","volume":"116","author":"Z Wu","year":"2019","unstructured":"Wu Z, et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci U S A. 2019;116(8):2996\u20133005.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2162_CR34","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41556-023-01133-9","volume":"25","author":"K Wu","year":"2023","unstructured":"Wu K, et al. Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function. Nat Cell Biol. 2023;25(5):714\u201325.","journal-title":"Nat Cell Biol"},{"issue":"7","key":"2162_CR35","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1158\/0008-5472.CAN-22-3169","volume":"83","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. HBx-induced HSPA8 stimulates HBV replication and suppresses ferroptosis to support liver cancer progression. Cancer Res. 2023;83(7):1048\u201361.","journal-title":"Cancer Res"},{"issue":"5","key":"2162_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","volume":"16","author":"JK Eaton","year":"2020","unstructured":"Eaton JK, et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat Chem Biol. 2020;16(5):497\u2013506.","journal-title":"Nat Chem Biol"},{"key":"2162_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144\u201352.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"2162_CR38","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180\u201391.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"2162_CR39","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.freeradbiomed.2012.02.043","volume":"52","author":"SE Yoo","year":"2012","unstructured":"Yoo SE, et al. Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain. Free Radic Biol Med. 2012;52(9):1820\u20137.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"2162_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1084\/jem.20140857","volume":"212","author":"M Matsushita","year":"2015","unstructured":"Matsushita M, et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med. 2015;212(4):555\u201368.","journal-title":"J Exp Med"},{"issue":"1","key":"2162_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood-2015-06-654194","volume":"127","author":"O Canli","year":"2016","unstructured":"Canli O, et al. Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood. 2016;127(1):139\u201348.","journal-title":"Blood"},{"issue":"7","key":"2162_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41419-021-04008-9","volume":"12","author":"Q Hu","year":"2021","unstructured":"Hu Q, et al. GPX4 and vitamin E cooperatively protect hematopoietic stem and progenitor cells from lipid peroxidation and ferroptosis. Cell Death Dis. 2021;12(7):706.","journal-title":"Cell Death Dis"},{"issue":"5","key":"2162_CR43","doi-asserted-by":"publisher","first-page":"e2797","DOI":"10.1038\/cddis.2017.176","volume":"8","author":"B Xu","year":"2017","unstructured":"Xu B, et al. Disulfiram\/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-kappaB and Nrf2. Cell Death Dis. 2017;8(5):e2797.","journal-title":"Cell Death Dis"},{"issue":"4","key":"2162_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00109-023-02414-4","volume":"102","author":"M Karsa","year":"2024","unstructured":"Karsa M, et al. FDA-approved disulfiram as a novel treatment for aggressive leukemia. J Mol Med (Berl). 2024;102(4):507\u201319.","journal-title":"J Mol Med (Berl)"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-024-02162-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:26:04Z","timestamp":1730107564000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-024-02162-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2162"],"URL":"https:\/\/doi.org\/10.1186\/s12943-024-02162-0","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of the First Affiliated Hospital of Jinan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"240"}}